title: Using the cancer registry to meet the Commission on Cancer clinical trials accrual standard.
abstract: Clinical trials are an important tool for innovation in cancer treatments. Therefore, accrual into trials has been highlighted for Commission on Cancer (CoC)-accredited hospital programs. The current Standard 5.21 and Standard 1.92 which take effect in 2015 require a minimum percentage of patient enrollment for compliance, as well as an opportunity for commendation at a higher percentage. The standards do not define a role for the hospital cancer registry staff but, at C/NET Solutions, we believe that the data collection and management efforts of the registry can be leveraged to effectively screen patients for clinical trials accrual.
authors.forename: Alan
authors.initials: A
authors.lastname: Houser
authors.forename: Dan
authors.initials: D
authors.lastname: Curran
authors.forename: Valerie
authors.initials: V
authors.lastname: Spadt
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards*; D003628:Database Management Systems / Q000458:organization & administration*; D006801:Humans; D008495:Medical Oncology; D009369:Neoplasms; D018579:Patient Selection; D012042:Registries